Accordingly, while lanthanide nanoparticles and other high-Z materials have each been investigated as radiosensitizers and may influence immune mechanisms (e.g., enhanced immunogenic cell death and tumor microenvironment modulation), the current evidence base does not support definitive comparative conclusions regarding their relative effectiveness when combined with PD-1/PD-L1 blockade. The gene discussed is CD274; the disease is neoplasm.